2025-05-20T10:36:36-07:00 2024-08-31 990 2023-09-01 203674498 GLOBAL HEALTH SOLUTIONS INC GLOB 4045921430 330 W Ponce de Leon Ave Decatur GA 300303001 Ellen Wild Chief Operating Officer 4046875607 2025-04-30 1 2023 2025-03-06 01:10:19Z Ellen Wild 330 W Ponce de Leon Ave Decatur GA 30030 511468181 0 X www.taskforce.org X 2005 GA As a supporting organization, provide support to the global health initiatives of The Task Force for Global Health,Inc. 4 0 0 0 0 0 628809066 511468181 0 0 0 0 0 0 628809066 511468181 628809066 511468181 0 0 0 0 0 0 0 0 0 628809066 511468181 0 0 0 0 0 0 0 0 As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and coordinating the shipment to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases. 0 0 458632706 0 458632706 The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of azithromycin to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2023 and August 2024, ITI organized just-in-time shipments of 33.3 million treatments for trachoma to be distributed at MDAs in 15 countries. As of August 2024, ITI has shipped more than 1.073 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 3,823 surveys across 52 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.2 billion people in 2000 to 103.2 million in April 2024 according to the World Health Organization's (WHO) Weekly Epidemiological Record (WER). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality. 52835475 0 52835475 Mectizan Donation Program Accomplishments In 2024, 406.1 million Mectizan treatments were approved for mass drug administration (MDA) for onchocerciasis and lymphatic filariasis (LF) elimination in 44 countries and territories. The breakdown of treatments approved is as follows: (a) 274.1 million for onchocerciasis only including 63 million treatments approved to implement a second round of treatment in 9 countries (Burkina Faso, DRC, Ethiopia, Ghana, Malawi, Nigeria, Tanzania, Togo, and Uganda). (b) 36.2 million for onchocerciasis & LF co-endemic communities. (c) 95.7 million for LF only, of which 52.8 million were approved for 14 countries implementing triple therapy with ivermectin, DEC, and albendazole (IDA). By the end of 2024, cumulatively, the number of Mectizan 3mg tablets shipped since the inception of the program reached 13.9 billion or 4.94 billion treatments. The 5 billionth treatment shipped will be reached in early 2025, a very exciting milestone that the Mectizan Donation Program (MDP) will celebrate with Merck & Co., Inc. and other partners working to eliminate these diseases. Timor Leste was validated by WHO for achieving the elimination of LF as a public health problem, the first country to achieve elimination using triple therapy with the WHO-recommended triple therapy strategy: ivermectin, DEC and albendazole (IDA). A press release was issued by MDP to congratulate the country. MDP supported WHO-HQ to prepare a request to be submitted to Merck for Mectizan donation to extend the donation of Mectizan for - triple therapy - or IDA (ivermectin, diethylcarbamazine, and albendazole. The application was submitted to Merck in November 2024 for consideration. MDP also supported WHO, country partners, and others in identifying challenges and creating solutions to ensure onchocerciasis and lymphatic filariasis remain on track to meet the goals established in the WHO 2021-2030 Road Map. A robust communications and advocacy plan including an annual report, social media, video production, and e-newsletter was implemented to share progress and relevant developments with partners. Our film - Eliminating Disease with Mectizan - produced in 2023 (renamed - The Pill That's Changed Millions of Lives) was entered by the producer in the 2024 Smiley Charity Awards, a high-profile award in the UK for non-profit causes. The film was selected as a finalist in the - Corporate Cause - and SDG 3 categories. The film did not win the award; however, this increased visibility for the donation of Mectizan and efforts to eliminate onchocerciasis and lymphatic filariasis. 0 0 0 511468181 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 4 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 GA X X Daniel N Martins 4046875620 330 W Ponce de Leon Ave Decatur GA 300303001 Patrick O'Carroll Chairman 1 39 X 0 411644 0 Mark McKinlay Officer 1 39 X X 0 387309 0 William P Nichols Officer 1 39 X X 0 339114 0 Daniel N Martins Secretary 1 39 X 0 253744 0 Ellen Wild Treasurer 1 39 X 0 227921 0 0 1619732 0 0 1 1 0 0 0 0 0 0 511468181 0 511468181 0 0 0 0 0 0 0 511468181 0 0 0 511468181 511468181 511468181 511468181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 1 X 1 1 1 X X X 1 THE TASK FORCE FOR GLOBAL HEALTH INC Type I 581698648 7 1 0 511468181 1 0 511468181 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 511468181 0 0 0 0 0 511468181 0 0 0 511468181 511468181 0 0 0 0 0 511468181 0 0 0 511468181 Schedule D, Part VI, Line 1a The Organization does not own any assets and does not owe any liabilities and so does not have a balance sheet. 1 East Asia and the Pacific 0 0 Program Services Donation of zithromax drug for the treatment of blinding trachoma 5403353 Middle East and North Africa 0 0 Program Services Donation of zithromax drug for the treatment of blinding trachoma. 11474201 Sub-Saharan Africa 0 0 Program Services Donation of zithromax drug for the treatment of blinding trachoma. 441755152 East Asia and the Pacific 0 0 Program Services Donation of mectizan drug for the treatment of lymphatic filariasis. 2663535 South America 0 0 Program Services Donation of mectizan drug for the treatment of lymphatic filariasis. 384405 South Asia 0 0 Program Services Donation of mectizan drug for the treatment of lymphatic filariasis. 25009845 Sub-Saharan Africa 0 0 Program Services Donation of mectizan drug for the treatment of lymphatic filariasis. 24683190 Central America and the Caribbean 0 0 Program Services Donation of mectizan drug for the treatment of lymphatic filariasis. 94500 0 0 511468181 Central America and the Caribbean Donation of mectizan drug for the treatment of lymphatic filariasis. 0 0 94500 Mectizan drug Lower of market or donor's cost. East Asia and the Pacific For the treatment of lymphatic filariasis and blinding trachoma. 0 N/A 8066888 Drug donation - mectizan and zithromax Lower of market or donor's costs Middle East and North Africa For the treatment of blinding trachoma. 0 N/A 11474201 Donated drugs - zithromax Lower of market or donor's cost South America For the treatment of lymphatic filariasis. 0 N/A 384405 Drug donation - Mectizan Lower of market or donor's cost South Asia For the treatment of lymphatic filariasis. 0 N/A 25009845 Drug donation - Mectizan Lower of market or donor's cost Sub-Saharan Africa For the treatment of lymphatic filariasis and blinding trachoma. 0 N/A 466438342 Drug donation - mectizan and zithromax Lower of market or donor's cost 34 0 0 0 0 0 0 1 Schedule F, Part I, Line 2 The In-Kind Contributions are shipped directly by the donors to the countries where they are needed. Global Health Solutions obtains the shipping documents for processing in the accounting system. Occasional site visits are carried out in some countries to assess and evaluate the impact of the program activities. In our Ethiopia country office, an audit firm is appointed to ensure that things are done in compliance to required rules and regulations. 0 0 0 0 0 0 0 0 0 Patrick O'Carroll Chairman 0 380636 0 0 0 0 0 29700 0 1308 0 411644 0 0 Ellen Wild Officer 0 201573 0 7000 0 0 0 18274 0 1074 0 227921 0 0 Daniel N Martins Treasurer 0 182089 0 9194 0 0 0 16825 0 45636 0 253744 0 0 William P Nichols Officer 0 310032 0 0 0 0 0 27903 0 1179 0 339114 0 0 Mark McKinlay Member 0 316424 0 0 0 0 0 28960 0 41925 0 387309 0 0 Schedule J, Part I, Line 3 The organization does not have employees but has officers who are paid by the related organization X 2 511468181 Lower of market cost or donor's cost 0 1 1 Schedule M, Part I, Line 32b Drugs donated are shipped by third parties Form 990, Part VI, Section B, Line 11b Once Form 990 is completed, it is emailed as a pdf file to each board member and officers for their review and comments. They are required to notify the organization with any issues or concerns they may have. Form 990, Part VI, Section B, Line 12c The organization does not have employees but has officers. At the end of every fiscal year, all officers are required to read and sign all relevant policies. Form 990, Part VI, Section C, Line 19 The financial information for three fiscal years is available on the organization's website together with its Form 990 reports and conflict of interest policy. The Task Force for Global Health Inc 330 W Ponce de Leon Ave Decatur GA 30030 581698648 Management and distribution of donated medicines GA 501(c)(3) 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0